BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liang C, Wu HM, Yu WM, Chen W. Research status on immunotherapy trials of gastric cancer. World J Clin Cases 2021; 9(21): 5782-5793 [PMID: 34368297 DOI: 10.12998/wjcc.v9.i21.5782]
URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5782.htm
Number Citing Articles
Min Fu, Yongbiao Huang, Xiaohong Peng, Xiaoyu Li, Na Luo, Wenjun Zhu, Feng Yang, Ziqi Chen, Shengling Ma, Yuanyuan Zhang, Qianxia Li, Guangyuan Hu. Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach AdenocarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.790920
Fei Jiang, Xiaowei Chen, Yan Shen, Xiaobing Shen. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway–Related Prognostic Prediction Model in Gastric CancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.891744
Li Xiang, Chuan Lan, Luca Falzone. Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer PatientsInternational Journal of Genomics 2022; 2022: 1 doi: 10.1155/2022/7684606
Safia Samir, Hend Okasha Ahmed, Tarek M. Diab, Amr Mostafa, Hesham A. Elmeligy, Amira Kamel, Heba Khalil. Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 ImmunoreactivityOpen Access Macedonian Journal of Medical Sciences 2022; 10(A): 1218 doi: 10.3889/oamjms.2022.9700
Youngdong Choi, Hong Kyu Lee, Dohee Ahn, Min-Woo Nam, Ryeo-Eun Go, Kyung-Chul Choi. Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse modelLife Sciences 2023; 328: 121866 doi: 10.1016/j.lfs.2023.121866
Ning Li, Zhi Li, Qiang Fu, Bin Zhang, Jian Zhang, Xiang-Bin Wan, Chao-Min Lu, Jin-Bang Wang, Wen-Ying Deng, Yi-Jie Ma, Liang-Yu Bie, Meng-Yu Wang, Jing Li, Qing-Xin Xia, Chen Wei, Su-Xia Luo. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II studyInternational Journal of Surgery 2024; 110(4): 2071 doi: 10.1097/JS9.0000000000001119